Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-28

Clinical Trial Update: Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

View source ↗

Summary

A completed substudy within the ATN 024/025 trials examining genetic factors related to the Hepatitis B vaccine in individuals with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV Infection, Hepatitis B | Status: COMPLETED